Fibroblast growth factor receptor-1 expression in the cortex and hippocampus in Alzheimer's disease

Brain Res. 1998 Aug 17;802(1-2):89-97. doi: 10.1016/s0006-8993(98)00552-6.

Abstract

Localization of fibroblast growth receptor (FGFR)-1 immunoreactivity was investigated immunochemically in postmortem brain tissue of Alzheimer's disease (AD) and age-matched control cases using a rabbit polyclonal antibody and a mouse monoclonal antibody specific for FGFR-1. In control cases, FGFR-1 immunoreactivity was identified in astrocytes in white matter and in hippocampal pyramidal neurons. In AD cases, the immunoreactivity in reactive astrocytes surrounding senile plaques was increased. The pattern of FGFR-1 immunoreactivity was confirmed in selected cases by in situ hybridization for FGFR-1 mRNA. Immunoreactivity using a monoclonal antibody demonstrated a similar distribution pattern. The localization of FGFR-1 is consistent with previous reports on the involvement of FGF-1 and FGF-2 in AD.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / metabolism*
  • Animals
  • Antibodies, Monoclonal
  • Astrocytes / metabolism
  • Brain / metabolism
  • Cerebral Cortex / metabolism*
  • Cerebral Cortex / pathology
  • Hippocampus / metabolism*
  • Hippocampus / pathology
  • Humans
  • Immunoblotting
  • Immunohistochemistry / methods
  • In Situ Hybridization
  • Mice
  • Pyramidal Cells / metabolism
  • Rabbits
  • Receptors, Fibroblast Growth Factor / metabolism*
  • Reference Values

Substances

  • Antibodies, Monoclonal
  • Receptors, Fibroblast Growth Factor